ISPOR ANNOUNCES PLENARY SESSIONS AND SPEAKERS FOR 19TH ANNUAL EUROPEAN CONGRESS

To Be Held 29 October–2 November 2016 in Vienna, Austria 

Princeton, NJ—September 12, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced plenary sessions and speakers for its 19th Annual European Congress that will be held 29 October–2 November 2016 in Vienna, Austria. The congress will explore topics related to the conference theme—Managing Access to Medical Innovation: Strengthening the Methodology-Policy Nexus.

The first plenary session, What Synergies Could Be Created Between Regulatory and Health Technology Assessments, is scheduled for Monday, 31 October 2016 and will explore potential synergies in the work and processes of regulators and health technology assessment (HTA) bodies that could be realized by addressing roadblocks in the European Union (EU) health sector ecosystem. Plenary speakers include:

  • Moderator:Hans-Georg Eichler, MD, MSc, Senior Medical Officer, European Medicines Agency (EMA), London, UK
  • Speaker:Guido Rasi, Executive Director, European Medicines Agency (EMA), London, UK
  • Speaker:Wim Goettsch, PhD, Secretariat Director, EUnetHTA JA3, Diemen, The Netherlands
  • Speaker:Andrzej Rys, Director, Health Systems, Medical Products and Innovation, European Commission, Brussels, Belgium
  • Speaker:Jens Grueger, PhD, Vice President and Head of Global Pricing and Market Access, F. Hoffmann-LaRoche, Basel, Switzerland

The second plenary, Differential Pricing of Medicines in Europe: Implications for Access, Innovation, and Affordability, will be held Tuesday, 1 November 2016 and will consider options for a defined and systematic approach to promoting efficient differential pricing in Europe. Plenary speakers include:

  • Moderator:Lou Garrison, PhD, Professor, Pharmaceutical Outcomes Research and Policy Program, School of Pharmacy, University of Washington, Seattle, WA, USA
  • Speaker:Sabine Vogler, PhD, Program Coordinator, Pharmacoeconomics and Pharmaceutical Policy Analysis, Head of the WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies, Gesundheit Österreich GmbH (GÖG / Austrian Public Health Institute), Vienna, Austria
  • Speaker:Jo De Cock, Chief Executive Officer, National Institute of Health and Disability Insurance (NIHDI), Brussels, Belgium
  • Speaker:Elias Mossialos, Brian Abel-Smith Professor of Health Policy, Department of Social Policy, London School of Economics and Political Science, London, UK
  • Speaker:Adrian Towse, MA, MPhil, Director, Office of Health Economics, London, UK

The third and final plenary session, How to Control Costs and Improve Access to Medicines: Lessons From the InterQuality Project, will be held Wednesday, 2 November 2016 and will describe a number of important themes emerging from the International Research Project on Financing Quality in Healthcare—InterQuality. Speakers will include:

  • Moderator:Tomasz Hermanowski, PhD, InterQuality Project Leader and Professor and Head, Department of Pharmacoeconomics, Medical University of Warsaw, Warsaw, Poland
  • Speaker:Anna Zawada, MSc, Director, Transparency and Tariff Councils Office, Agency for Health Technology Assessment and Tariff System (AOTMiT), Warsaw, Poland
  • Speaker:Joanna Lis, MSc, MBA, PhD, Director, Market Access, Sanofi-Aventis, Warsaw, Poland
  • Speaker:Axel Muehlbacher, PhD, Professor, Neubrandenburg University, Neubrandenburg, Germany
  • Speaker:Brian K. Solow, MD, FAAFP, Chief Medical Officer, Optum Life Sciences, Irvine, CA, USA

ISPOR is globally recognized as the leading educational and scientific organization for health economics and outcomes research (HEOR) and its use in health care decision making. The ISPOR 19th Annual European Congress is the Society’s largest annual conference and draws a wide variety of health care stakeholders and thought leaders worldwide who have an interest in HEOR.

###

Posted in Announcements, ISPOR News & Press Tagged with: , , , , , , , ,